Health Care/Hospital

Nano Retina Announces Preliminary Results for First-in-Human Implantation of Its NR600 Artificial Retina Device

The device is designed to restore vision to persons blinded by age-related macular degeneration and retinitis pigmentosa First two patients to receive the device in March 2020 report visual effect HERZLIYA, Israel, March 30, 2020 /PRNewswire/ -- Nano Retina Ltd., developer of the NR600, an artif...

2020-03-30 08:00 1957

Ascentage Pharma Releases 2019 Annual Results, Reports Increased Investment in R&D and Advances in Global Clinical Development

SUZHOU, China and ROCKVILLE, MD, March 29, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today released its annual results for the...

2020-03-30 08:00 1698

Amerigo Education Responds to COVID-19 Impact

CHICAGO, March 30, 2020 /PRNewswire/ -- Amerigo Education, the leading provider of comprehensive boarding programs for international students, today shared its strategies to help protect students' health and wellbeing during the outbreak of coronavirus (COVID-19.) Amerigo started taking proactive...

2020-03-30 07:00 2306

Amerigo Education Responds to COVID-19 Impact

CHICAGO, March 29, 2020 /PRNewswire/ -- Amerigo Education, the leading provider of comprehensive boarding programs for international students, today shared its strategies to help protect students' health and wellbeing during the outbreak of coronavirus (COVID-19.) Amerigo started taking proactive...

2020-03-30 07:00 1528

Trip.com Group Chairman James Liang: Beware the xenophobia epidemic

SHANGHAI, March 29, 2020 /PRNewswire/ -- James Liang is an economist and entrepreneur. Trip.com Group Ltd. is one of the world's largest OTAs. The following are his thoughts on current events. These opinions are his own, and do not necessarily reflect those of Trip.com Group Ltd. as a whole: The...

2020-03-29 20:07 1829

Ping An Donates US$1.5 million of COVID-19 Medical Supplies to Indonesia

HONG KONG and SHANGHAI, March 28, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that in response to the Extraordinary G20 Leaders' Summit's call to supportIndonesia in fighting the COVID-19 epidemic, Ping...

2020-03-28 00:57 9806

GenScript ProBio Congratulates XlifeSciences on the Start of TAEST16001 Early Phase Clinical Trial

NANJING, China, March 27, 2020 /PRNewswire/ -- Guangzhou XlifeSciences, a partner of GenScript ProBio (GenScript's CDMO segment), announced that the early phase clinical trial of TAEST16001 project has been started. GenScript ProBio extends congratulations on this. This clinical trial project is...

2020-03-27 21:00 2791

GenScript ProBio Congratulates XlifeSciences on the Start of TAEST16001 Early Phase Clinical Trial

NANJING, China, March 27, 2020 /PRNewswire/ -- Guangzhou XlifeSciences, a partner of GenScript ProBio (GenScript's CDMO segment) announced that the early phase clinical trial of TAEST16001 project has been started. GenScript ProBio extends congratulations on this. This clinical trial project is ...

2020-03-27 21:00 2260

Airbnb to Help Provide Housing to 100,000 COVID-19 Responders

* New global initiative will provide free or subsidized housing for healthcare professionals, relief workers, and first responders, typically closer to where they are working  * Airbnb Hosts can opt in to provide homes that follow new cleanliness protocols based on recommendations from medica...

2020-03-27 20:09 5095

Foresee Pharmaceuticals and Accord Healthcare Announce MAA Submission for Camcevi(R) 42mg

TAIPEI, March 27, 2020 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee") and Accord Healthcare announced today that a Marketing Authorization Application (MAA) forCamcevi® 42mg (FP-001 LMIS 50mg), a ready-to-use 6-month depot formulation of leuprolide mesylate, has been su...

2020-03-27 19:53 3910

111 and Wenjiang People's Hospital to Build Online Cancer Diagnosis and Treatment Platform

SHANGHAI, March 27, 2020 /PRNewswire/ -- China's leading online pharmaceutical network and healthcare service provider is partnering with the Wenjiang People's Hospital inChengdu to build an online cancer diagnosis and treatment platform for rare tumors using imported drugs. The new rare tumor pl...

2020-03-27 19:36 4670

Alphamab Oncology Announces Clinical Supply Collaboration with Pfizer on KN026 in Combination with Ibrance(R) (palbociclib)

SUZHOU, China, March 27, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966HK) announced today that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab"), a wholly-owned subsidiary of the Company, has entered a clinical supply agreement with Pfizer Inc. ("Pfizer") to advance a ...

2020-03-27 19:00 4259

HotForex Makes Generous Donation to WHO Amid COVID-19 Crisis

In line with its commitment to social responsibility, award winning broker HotForex has made a generous donation to the World Health Organization amid the fight against the COVID-19 pandemic. PORT LOUIS, Mauritius, March 27, 2020 /PRNewswire/ -- HotForex, the award-winning forex and commodities ...

2020-03-27 18:00 4285

Luye Pharma Continues to Deliver Strong Growth in 2019

SHANGHAI, March 27, 2020 /PRNewswire/ -- Luye Pharma Group (02186.HK) reported its financial results for 2019 onMarch 27, 2020. According to the results, the company has achieved a total revenue ofRMB 6.358 billion, up 22.9% year-on-year. EBITDA wasRMB 2.488 billion, up 26.9% year-on-year; and n...

2020-03-27 16:44 5612

CStone submits new drug application for the targeted therapy avapritinib in Taiwan for the treatment of adults with advanced PDGFRA exon 18 mutant gastrointestinal stromal tumor

SUZHOU, China, March 27, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the Company has submitted a New Drug Application (NDA) to the Taiwan Food and Drug Administration (TFDA) for avapritinib, a precision therapy being developed for the t...

2020-03-27 14:02 1604

Labuan IBFC's Financial Services Community Band Together to Contribute to the Relief Efforts in Combating COVID-19

LABUAN, Malaysia, March 27, 2020 /PRNewswire/ -- Labuan International Business and Financial Centre, Labuan IBFC's financial services and intermediation community have come together to assist local authorities in relief efforts via the pooling of resources.

2020-03-27 12:23 5122

PHBS Alumni Donate COVID-19 Test Kits to UK Hospitals

Shenzhen, China, March 26, 2020 /PRNewswire/ -- Threatened by the novel coronavirus (COVID-19) epidemic, the whole world is in urgent need of medical supplies to take preventive measures and to diagnose patients who have contracted the virus. Eleven board members of Peking University HSBC Busines...

2020-03-27 11:20 1859

LightInTheBox Makes Urgently Needed Medical Supplies Globally Available to Support Fight Against COVID-19

BEIJING, March 26, 2020 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a cross-border e-commerce platform that delivers products directly to consumers around the world, today announced that it is making urgently needed medical supplies globally av...

2020-03-27 09:44 5614

Falcon.io Announces It Will Provide Free Services to Global Health Organizations, Following an Initiative Led by Messenger

In response to the COVID-19 crisis, Falcon.io will offer complimentary services COPENHAGEN, March 27, 2020 /PRNewswire/ -- Falcon.io, a Cision company, announced it will participate in aglobal initiative that Messenger from Facebook launched this week, in response to COVID-19. The program connec...

2020-03-27 08:00 2320

C(2) PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment

LUXEMBOURG, March 27, 2020 /PRNewswire/ -- C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks of the active pharmaceutical ingredient (API), Digoxin. In early March,...

2020-03-27 07:33 2535
1 ... 804805806807808809810 ... 847

Week's Top Stories